Influence of electronic cigarette liquid flavors and nicotine concentration on subjective measures of abuse liability in young adult cigarette smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Cobb (2019)
assessing the association Between Electronic Cigarette Use among Cannabis-Naive adolescents and Future Cannabis Use-Overlapping Substances.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Compton (2022)
E-liquid alters oral epithelial cell function to promote epithelial to mesenchymal transition and invasiveness in preclinical oral squamous cell carcinoma.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
de Lima (2023)
e-Cigarette and Cigarette Use among Youth: Gateway or Common Liability?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Delnevo (2023)
Sensory experiences and cues among E-cigarette users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
DiPiazza (2020)
Vaping for weight control: Findings from a qualitative study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Dobbie (2020)
a randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ebajemito (2020)
Vaped humectants in E-Cigarettes are a Source of Phenols.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
El-hage (2020)
E-cigarette use is associated with subsequent cigarette use among young adult non-smokers, over and above a range of antecedent risk factors: a propensity score analysis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Epstein (2021)
Prospective associations of e-cigarette use with cigarette, alcohol, marijuana, and nonmedical prescription drug use among US adolescents.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Evans-Polce (2020)